IndexEffective Income Tax Rate Reconciliation, Deduction, Medicare Prescription Drug Benefit, Amount
| Name | IncomeTaxReconciliationDeductionsMedicarePrescriptionDrugBenefitSubsidy |
|---|---|
| Namespace | http://fasb.org/us-gaap/2020-01-31 |
| Prefix | us-gaap |
| Data type | xbrli:monetaryItemType |
| Period type | duration |
| Substitution Group | xbrli:item |
| Balance | credit |
| Nillable | True |
| Abstract | False |
Labels
| Text | Lang | Role | Container role |
|---|---|---|---|
| Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for Medicare prescription drug benefit subsidy. | en-US | http://www.xbrl.org/2003/role/documentation | http://www.xbrl.org/2003/role/link |
| Effective Income Tax Rate Reconciliation, Deduction, Medicare Prescription Drug Benefit, Amount | en-US | http://www.xbrl.org/2003/role/label | http://www.xbrl.org/2003/role/link |
References
| Name | Value | Role |
|---|---|---|
| Publisher | FASB | http://www.xbrl.org/2009/role/commonPracticeRef |
| Name | Accounting Standards Codification | http://www.xbrl.org/2009/role/commonPracticeRef |
| Topic | 740 | http://www.xbrl.org/2009/role/commonPracticeRef |
| SubTopic | 10 | http://www.xbrl.org/2009/role/commonPracticeRef |
| Section | 50 | http://www.xbrl.org/2009/role/commonPracticeRef |
| Paragraph | 12 | http://www.xbrl.org/2009/role/commonPracticeRef |
| URI | http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319 | http://www.xbrl.org/2009/role/commonPracticeRef |